Abstract
BackgroundColon neuroendocrine neoplasms (NENs) have one of the poorest median overall survival (OS) rates among all NENs. The American Joint Committee on Cancer (AJCC) tumor–node–metastasis (TNM) staging system—currently the most commonly used prediction model—has limited prediction accuracy because it does not include parameters such as age, sex, and treatment. The aim of this study was to construct nomograms containing various clinically important parameters to predict the prognosis of patients with colon NENs more accurately.MethodsUsing the Surveillance, Epidemiology, and End Results (SEER) database, we performed a retrospective analysis of colon NENs diagnosed from 1975 to 2016. Data were collected from 1196 patients; almost half were female (617/1196, 51.6%), and the average age was 61.94 ± 13.05 years. Based on the age triple cut-off values, there were 396 (33.1%), 408 (34.1%), and 392 (32.8%) patients in age groups 0–55 years, 55–67 years, and ≥ 68 years, respectively. Patients were randomized into training and validation cohorts (3:1). Independent prognostic factors were used for construction of nomograms to precisely predict OS and cancer-specific survival (CSS) in patients with colon NENs.ResultsMultivariate analysis showed that age ≥ 68 years, sex, tumor size, grade, chemotherapy, N stage, and M stage were independent predictors of OS. In the validation cohort, the Concordance index (C-index) values of the OS and CSS nomograms were 0.8345 (95% confidence interval [CI], 0.8044–0.8646) and 0.8209 (95% CI, 0.7808–0.861), respectively. C-index also indicated superior performance of both nomograms (C-index 0.8347 for OS and 0.8668 for CSS) compared with the AJCC TNM classification (C-index 0.7159 for OS and 0.7366 for CSS).ConclusionsWe established and validated new nomograms for more precise prediction of OS and CSS in patients with colon NENs to facilitate individualized clinical decisions.
Highlights
Colon neuroendocrine neoplasms (NENs) have one of the poorest median overall survival (OS) rates among all NENs
Colon and rectal NENs are often described as a single disease, recent evidence has indicated that depending on tumor grade, the median overall survival (OS) of colon NENs is poor compared with most gastrointestinal NENs, and the prognosis is much worse than that of rectal NENs [2, 3]
Data retrieved from the SEER database Specific clinicopathological data and prognostic outcomes of patients with colon NENs were retrieved from the SEER database submitted in November 2018 [16]
Summary
Colon neuroendocrine neoplasms (NENs) have one of the poorest median overall survival (OS) rates among all NENs. The American Joint Committee on Cancer (AJCC) tumor–node–metastasis (TNM) staging system— currently the most commonly used prediction model—has limited prediction accuracy because it does not include parameters such as age, sex, and treatment. Colon and rectal NENs are often described as a single disease, recent evidence has indicated that depending on tumor grade, the median overall survival (OS) of colon NENs is poor compared with most gastrointestinal NENs, and the prognosis is much worse than that of rectal NENs [2, 3]. Compared with rectal NENs, colon NENs have larger size, higher T stage, higher grade, and more frequent lymph nodes and lymphovascular invasion positivity. The 5-year disease-specific survival is significantly different, and treatment options are very limited, which leads to worse outcomes [1, 7, 8]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
